...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Léogane, Haiti
【24h】

A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Léogane, Haiti

机译:纵向药物对海地莱奥甘淋巴水肿患者急性炎症发作和疾病进展的影响的纵向分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We conducted a longitudinal analysis of 117 lymphedema patients in a filariasis-endemic area of Haiti during 1995-2008. No difference in lymphedema progression between those who received or did not receive mass drug administration (MDA) was found on measures of foot (P = 0.24), ankle (P = 0.87), or leg (P = 0.46) circumference; leg volume displacement (P = 0.09), lymphedema stage (P = 0.93), or frequency of adenolymphangitis (ADL) episodes (P = 0.57). Rates of ADL per year were greater after initiation of MDA among both groups (P < 0.01). Nevertheless, patients who received MDA reported improvement in four areas of lymphedema-related quality of life (P ≤ 0.01). Decreases in foot and ankle circumference and ADL episodes were observed during the 1995-1998 lymphedema management study (P ≤ 0.01). This study represents the first longitudinal, quantitative, leg-specific analysis examining the clinical effect of diethylcarbamazine on lymphedema progression and ADL episodes.
机译:我们对1995-2008年海地丝虫病流行地区的117名淋巴水肿患者进行了纵向分析。在足部(P = 0.24),踝部(P = 0.87)或腿部(P = 0.46)的测量值上,未接受或未接受大规模药物治疗(MDA)的患者之间的淋巴水肿进展无差异;腿体积移位(P = 0.09),淋巴水肿分期(P = 0.93)或腺淋巴炎(ADL)发作的频率(P = 0.57)。两组MDA开始后,每年的ADL比率更高(P <0.01)。然而,接受MDA治疗的患者报告在四个方面与淋巴水肿有关的生活质量有所改善(P≤0.01)。在1995年至1998年的淋巴水肿管理研究期间,观察到脚和踝围和ADL发作减少(P≤0.01)。这项研究代表了首次纵向,定量,腿特异性的分析,检查了二乙基卡巴嗪对淋巴水肿进展和ADL发作的临床作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号